Bolt Biotherapeutics - Crunchbase Company Profile & Funding

Q: Who invested in Bolt Biotherapeutics?

Bolt Biotherapeutics has 11 investors including Genmab And Samsara BioCapital.

Q: How much funding has Bolt Biotherapeutics raised to date?

Bolt Biotherapeutics has raised obfuscated.

Overview

Bolt Biotherapeutics

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Bolt Biotherapeutics

CB Rank

111801

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy.

Founded

obfuscation

Public

Post-IPO Equity

Redwood City, California, United States

51-100

boltbio.com/

Biotechnology

Health Care

Medical

Pharmaceutical

Funding Rounds

Post-IPO Equity

OBF

obfuscation

Series C

OBF

obfuscation

Series B

OBF

obfuscation

Key People

Edgar Engleman: Founder
Chih-Ping Liu: Co-Founder

Details

Legal Name

Bolt Biotherapeutics, Inc.

Also Known As

Bolt Therapeutics

Operating Status

Active

Stock Symbol

NASDAQ:BOLT

Company Type

For Profit

Founders

Chih-Ping Liu, Edgar Engleman

About the Company

Bolt Biotherapeutics is a biotechnology company that develops a platform for cancer immunotherapy. Its platform, Boltbody, is a cancer immunotherapy that consists of immune-stimulating antibody conjugates.

Phone Number

(310)909-3218

Contact Email

info@bOLTBIO.com

Predictions & Insights

Growth Insight

See this Growth Insight

Bolt Biotherapeutics is

Lorem

to be growing

Top Contributing Factors

Headcount Reduction

Products & Services

BDC-3042

A Dectin-2 agonist antibody that repolarizes tumor-associated macrophages from tumor-supportive to tumor-destructive, currently in Phase 1 clinical trial.

Boltbody™ Immune-Stimulating Antibody Conjugate (ISAC) Platform

A platform technology that creates tumor-targeting antibody conjugates to activate the innate immune system and induce a localized anti-tumor immune response.

Research & Development

Bolt Biotherapeutics is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity
obfuscated obfuscation	Post-IPO Equity - Bolt Biotherapeutics	1	obfuscated obfuscation	—	Post-IPO Equity

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Genmab	No	Post-IPO Equity - Bolt Biotherapeutics	—
Genmab	No	Post-IPO Equity - Bolt Biotherapeutics	—
Genmab	No	Post-IPO Equity - Bolt Biotherapeutics	—
Genmab	No	Post-IPO Equity - Bolt Biotherapeutics	—
Genmab	No	Post-IPO Equity - Bolt Biotherapeutics	—